C Gilbert|R L Gilbert - JoVE Visualize

Showing results (721-730 of 951) with videos related to

Pageof 96

Sort By:

Vaccine|February 21, 2006

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.

Circulation|November 21, 2007

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteersJames C Gilbert, Tia DeFeo-Fraulini, Renta M Hutabarat, et al.

Oncotarget|July 20, 2019

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivoElgilda Musi, Gary K Schwartz, Jae Hyuk Yoo, et al.

Plos One|August 21, 2014

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.

Journal of Pediatric Surgery|July 11, 1998

Cervical ECMO cannula placement in infants and children: recommendations for assessment of adequate positioning and functionM S Irish, S J O'Toole, P Kapur, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.

Human Vaccines|January 12, 2010

Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.

International Journal of Cancer|September 24, 2004

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.

Vaccine|April 23, 2003

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.

Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 29, 2011

Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cellsChao Yu, Max Crispin, Andreas F-P Sonnen, et al.

Pageof 96

Showing results (721-730 of 951) with videos related to

Sort By:

Pageof 96

Vaccine|February 21, 2006

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.

Circulation|November 21, 2007

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteersJames C Gilbert, Tia DeFeo-Fraulini, Renta M Hutabarat, et al.

Oncotarget|July 20, 2019

Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivoElgilda Musi, Gary K Schwartz, Jae Hyuk Yoo, et al.

Plos One|August 21, 2014

4-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaquesAlexandra J Spencer, Julie Furze, Jared D Honeycutt, et al.

Journal of Pediatric Surgery|July 11, 1998

Cervical ECMO cannula placement in infants and children: recommendations for assessment of adequate positioning and functionM S Irish, S J O'Toole, P Kapur, et al.

Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.

Human Vaccines|January 12, 2010

Prime-boost vectored malaria vaccines: progress and prospectsAdrian V S Hill, Arturo Reyes-Sandoval, Geraldine O'Hara, et al.

International Journal of Cancer|September 24, 2004

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrenceCaroline L Smith, P Rod Dunbar, Fareed Mirza, et al.

Vaccine|April 23, 2003

Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.

Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|July 29, 2011

Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cellsChao Yu, Max Crispin, Andreas F-P Sonnen, et al.

Pageof 96